Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Sperling

Showing results (471-480 of 625) with videos related to

Pageof 63
Sort By:
Epilepsia|June 17, 2010
Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsyJerome Engel, Michael P McDermott, Samuel Wiebe, et al.
Epilepsy Research|December 14, 2007
Prognosis after late relapse following epilepsy surgeryMichael R Sperling, Maromi Nei, Andro Zangaladze, et al.
Epilepsia|March 2, 2013
Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trialsDale C Hesdorffer, Jacqueline A French, Kelly Posner, et al.
Annals of Neurology|June 15, 2007
Health-related quality of life over time since resective epilepsy surgerySusan S Spencer, Anne T Berg, Barbara G Vickrey, et al.
Brain Stimulation|August 24, 2021
Theta-burst stimulation entrains frequency-specific oscillatory responsesEthan A Solomon, Michael R Sperling, Ashwini D Sharan, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Subjective Cognitive Decline in a Registry Sample: Relation to Psychiatric History, Loneliness, and PersonalityG O Reynolds, L Manning, D Kirn, et al.
Scientific Reports|November 2, 2021
Accuracy of high-frequency oscillations recorded intraoperatively for classification of epileptogenic regionsShennan A Weiss, Richard J Staba, Ashwini Sharan, et al.
Epilepsy & Behavior : E&B|May 6, 2021
Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety studyGregory D Cascino, Daniel Tarquinio, James W Wheless, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
The Journal of Prevention of Alzheimer'S Disease|August 7, 2015
Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task ForceB Vellas, R Bateman, K Blennow, et al.
Pageof 63

Showing results (471-480 of 625) with videos related to

Sort By:
Pageof 63
Epilepsia|June 17, 2010
Design considerations for a multicenter randomized controlled trial of early surgery for mesial temporal lobe epilepsyJerome Engel, Michael P McDermott, Samuel Wiebe, et al.
Epilepsy Research|December 14, 2007
Prognosis after late relapse following epilepsy surgeryMichael R Sperling, Maromi Nei, Andro Zangaladze, et al.
Epilepsia|March 2, 2013
Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trialsDale C Hesdorffer, Jacqueline A French, Kelly Posner, et al.
Annals of Neurology|June 15, 2007
Health-related quality of life over time since resective epilepsy surgerySusan S Spencer, Anne T Berg, Barbara G Vickrey, et al.
Brain Stimulation|August 24, 2021
Theta-burst stimulation entrains frequency-specific oscillatory responsesEthan A Solomon, Michael R Sperling, Ashwini D Sharan, et al.
The Journal of Prevention of Alzheimer'S Disease|July 16, 2022
Subjective Cognitive Decline in a Registry Sample: Relation to Psychiatric History, Loneliness, and PersonalityG O Reynolds, L Manning, D Kirn, et al.
Scientific Reports|November 2, 2021
Accuracy of high-frequency oscillations recorded intraoperatively for classification of epileptogenic regionsShennan A Weiss, Richard J Staba, Ashwini Sharan, et al.
Epilepsy & Behavior : E&B|May 6, 2021
Lack of observed tolerance to diazepam nasal spray (Valtoco®) after long-term rescue therapy in patients with epilepsy: Interim results from a phase 3, open-label, repeat-dose safety studyGregory D Cascino, Daniel Tarquinio, James W Wheless, et al.
The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.
The Journal of Prevention of Alzheimer'S Disease|August 7, 2015
Endpoints for Pre-Dementia AD Trials: A Report from the EU/US/CTAD Task ForceB Vellas, R Bateman, K Blennow, et al.
Pageof 63